Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

Introduction Large numbers of patients with type 2 diabetes receive treatment with a sodium-glucose co-transporter-2 inhibitor (SGLT2i). We investigated whether the cardiorenal preventative effects found in clinical trials are also seen in clinical practice where patient characteristics and adherenc...

Full description

Bibliographic Details
Main Authors: David Vizcaya, Antonio Gonzalez Perez, Maria E Sáez, Luis A Garcia Rodriguez
Format: Article
Language:English
Published: BMJ Publishing Group 2023-01-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/11/1/e003072.full

Similar Items

Similar Items